OMER
Companies
NASDAQ
Omeros Corporation
Health Care
$3.49
-$6.39 (-64.68%)
Price Chart
Overview
About OMER
omeros is a seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system.
Market Cap
$223.7M
Volume
7.5M
Avg. Volume
4.1M
P/E Ratio
-1.405983
Dividend Yield
0.00%
Employees
220.0
Company Information
Risk & Correlation Analysis
Market Correlation
2.12
High Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, OMER shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$223.7M
Volume7.5M
P/E Ratio-1.41
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 16, 2025Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025